Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-01-03
2006-01-03
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S009100, C424S009200, C424S184100, C424S185100, C424S192100, C424S200100, C424S234100, C424S248100, C435S041000, C435S069100, C435S243000, C435S253100, C530S300000, C530S350000
Reexamination Certificate
active
06982085
ABSTRACT:
The present invention is based on the identification and characterization of a number of novelM. tuberculosisderived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
REFERENCES:
patent: WO 95/01441 (1995-01-01), None
patent: WO 96/37219 (1996-11-01), None
patent: WO 97/09428 (1997-03-01), None
patent: WO 97/09429 (1997-03-01), None
patent: WO 98/16645 (1998-04-01), None
patent: WO 98/16646 (1998-04-01), None
patent: WO 98/16646 (1998-04-01), None
ABSTRACT, Accession No. 053519, Database EMBL [Online], Rv2185c, Jun. 1, 1998, XP002274823.
ABSTRACT, Accession No. 069575, Database EMBL [Online], ML0889, Aug. 1, 1998, XP002274824.
Hochestrasser, Denis F. et al.; “Methods for increasing . . . ” Analytical Biochemistry 173, 424-435 (1988).
Von Heijne, Gunanr; “How Signal Sequence maintain Cleavage Specificity” J. Mol. Biol. (1984) 173, 243-251.
Harboe, Morten et al.; “Evidence for occurence of the . . . ” Infection and Immunity Jan. 1996, p. 16-22.
Gosselin, Edmund et al.;“Enhabnced antigen presentation . . . ” Journal of Immunology vol. 149, 3477-3481 No. 11 Dec. 1, 1992.
Mahairas, Gregory G. et al.; “Molecular Analysis of . . . ” American Society for Microbiology Oct. 20, 1995.
Lindblad, Erik B. et al.; “Adjuvant Modulation of . . . ” Infection Immunity Feb. 1997, p. 623-629 vol. 65, No. 2.
Huayi, Li et al.; “Evidence for absence of the . . . ” Ibfection and Immunity May 1993, p. 1730-1734 vol., 61, No. 5.
Kohler, G. et al.; “Continuous cultures of . . . ” Nature vol. 256 Aug. 7, 1975.
Ploug, Michael et al.; “Determination of Amino. . . ” Analytical Biochemistry 181, 33-39 (1989).
Ohara, N. et al.; “Characterization of the Gene. . . ” Scand J. Immunol. 41, 433-442, 1995.
Oettinger, Thomas et al.; “Cloning and B-cell-epitope. . . ” Infection and Immunity May 1994, vol. 62, No. 5.
Nagai, Sadamu et al.; “Isolation and Partial. . . ” Infection and Immunity, Jan. 1991, p. 372-382 vol. 59, No. 1.
Rosenkrands, Ida et al.; “Indentifcation and Characterization of. . . ” Infection and Immunity Jun. 1998, p. 2728-2735 vol. 66, No. 6.
Roberts, A.D. eta l.; “Characteristics of protective immunity. . . ” Immunology 1995 85 502-508.
Porath, Jerker et al.; “Thiophilic adsorption-0a new method. . . ” FEBS Letters vol. 185, No. 2 FEBS 2631 Jun. 1985.
Valdes-Stauber, Natalia et al.; “Nucleotide Sequence and Taxonomical. . . ” Applie dand Environmental Microbiology, Apr. 1996, p. 1283-1286 vol. 62.
Valdes-Stauber, Natalia et al.; “Isolation and Characterization. . ” A[pplied and Environmental Microbiology, Oct. 1994, vol. 60, No. 10 pp. 3809-3814.
Theisen, Michael eta l.; “Antigenicity and Immunogenicity. . . ” Clinical and Diagnostic Lab. Immun. Jan. 1995, pp. 30-34 vol. 2, No. 1.
Sorensen, Anne L. et al.: “Purification and Characterization of a. . . ” Insection and immunity May 1995, p. 1710-1717 vol. 63, No. 5.
Young, Richard et al.; “Dissection ofMycrobacterium tuberculosis. . . ” Proc. Natl. Acad. Sci. vol. 82, pp. 2583-2587, May 1985.
Barkholt, Vibeke et al.; “Amino Acid Analysis: . . . ” Analytical Biochemistry 177, 318-322 (1989).
Borodovsky, Mark et al.; “Genmark: Parallel Gene . . . ” Computers Chem vol. 17, pp. 123-133, 1993.
Andersen, A.B. et al.; “Structure and Function . . . ” Infection Immunity Jun. 1992, pp. 2317-2323 vol., 60, No. 6.
Article “Europeans move on from Yeast to TB” Science vol. 272, Apr. 5, 1996.
Van Dyke, M.W. et al.; “Single-step purification . . . ” Gene pp. 99-104. (1992).
Brown, D. B. eta l.; “Mycrobacterium tuberculosiscosmid v035” Feb. 20, 1998 EMBL Sequences Database.
Rosenkrands, Ida et al.; “Mycrobacterium tuberculosiscfp29 gene” Jun. 30, 1997 EMBL:Y12820.
Churcher, C.M.C.; “Mycrobacterium tuberculosiscosmid v035” Feb. 20, 1998 EMBL:Y12820.
Crabtree, J.C. et al.; Homo sapiens clone 137c7 Mar. 19, 1997 EMBL sequence database.
Infection and Immunity 62(6) Jun. 1994 p. 2536-2544, Andersen, P “Effective vaccination of mice againstmyobacterium tuberculosisinfection . . . ”.
Journal of Immunological Methods 161 (1993) p. 29-39, Andersen, P et al. “Simultaneous electroelution of whole SDS-Polyacrylamide gels for the . . . ”.
The Journal of Immunology 154(1995) p. 3359-3372, Andersen, P et al. “Recall of long-lived immunity toMycobacterium tuberculosisinfection in mice”.
J. Mol. Biol. 215(1990) p. 403-410, Altschul, S et al. “Basic local alignment search tool”.
Infection and Immunity 66(5) Jun. 1998 p. 2951-2959, Baldwin, S et al. “Evaluation of new vaccines in the mouse and guinea pig model . . . ”.
Infection and Immunity 63(4) Apr. 1995 p. 1491-1497, Boesen, H et al “Human t-cell responses to secreted antigen fractions . . . ”.
J. Exp. Med. 178 (Dec. 1993) p. 2243-2247 Cooper et al. “Disseminatedtuberculosisin interferon . . . ”.
Immunology and Cell Biology 75(1997) p. 595-603 Elhay, M et al. “Immunological requirements for subunit vaccine . . . ”.
The Journal of Immunology 138 (Jun. 15, 1987) p. 4408-4413 Flesch, I et al. “Mycobacterial growth inhibition by interferon . . . ”.
J. Exp. Med. 178 (Dec. 1993) p. 2249-2254 Flynn, J et al. “An essential role for interferon . . . ”.
Proc. Natl. Acad. Sci. USA 92 (Feb. 1995) p. 1530-1534 Horwitz, M et al. “Protective immunity against tuberculosis induced . . . ”.
Advances in Applied Mathematics 12 (1991) p. 337-357 Huang, X et al. “A time-efficient, linear-space local similarity algorithm”.
Tetrahedron 54 (1998) p. 3607-3630 Koshkin, A et al. “LNA(Locked Nucleic Acids): Synthesis of the adenine, cytosine guanine, 5-methylcytosine . . . ”.
Immunology 25 (1973) p. 703-715 lefford, M et al. “Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats”.
J. Am. Chem. Soc. 120(22) 1998 p. 5458-5463 Christensen, N et al. “A novel class of olionucleotide analogues containing . . . ”.
Science 254 (Dec. 1991) p. 1497-1500 Nielsen, P et al. “Sequence-selective recognition of DNA by strand displacement . . . ”.
Infection and Immunity 56(12) Dec. 1988, p. 3310-3312 Orme, I “Induction of nonspecific acquired resistance and delayed-type . . . ”.
The Journal of Immunology 140(10) May 15, 1988 p. 3589*-3593 Orme, I “Characteristics and specificity of acquired immunologic memory . . . ”.
The Journal of Infections Diseases 167(1993) p. 1481-1497 Orme, I et al. “T cell rsponse tomycobacterium tuberculosis”.
Infection and Immunity 60(11) Nov. 1992 p. 4781-4792 Pal, P et al. “Immunization with extracellular proteins . . . ”.
Proc. Natl. Acad. Sci. USA 85(Apr. 1988) p. 2444-2448 Pearson, W et al. “Improved tools for biological sequence comparison”.
The Journal of Infectious Disease 179(3) Mar. 1999 Ravn, P et al. “Human T cell responses to ESAT-6 antigen . . . ”.
Res. Microbiol. 5th Forum in Microbiology, 141(1990) p. 253-256 Rook, G “The role of activated macrophages in protection and . . . ”.
Synthetic Oligonucleotide Probes 1989 p. 11.45-11.49 Sambrook et al. “Conditions for hybridization of oligonucleotide probes”.
Clin. Infect. Dis. 25(Sep. 1997) p. 617-620 Sodhi, A et al. “Clinical correlates of interferon . . . ”.
Nature 393(Jun. 11, 1998) 537-44 [erratum: 396(Nov. 12, 1998) 190-98] Cole et al. “Deciphering the biology ofMycobacterium tuberculosisfrom . . . ”.
Molecular Microbiology 7(2) (1993) 19
Andersen Peter
Florio Walter
Hansen Christina Veggerby
Okkels Li Mei Meng
Rasmussen Peter Birk
Birch & Stewart Kolasch & Birch, LLP
Statens Serum Institut
Swartz Rodney P
LandOfFree
TB diagnostic based on antigens from M. tuberculosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TB diagnostic based on antigens from M. tuberculosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TB diagnostic based on antigens from M. tuberculosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587663